GSE114212
Genetic compensation is triggered by mutant mRNA degradation
Genetic compensation by transcriptional modulation of related gene(s) (also known as transcriptional adaptation) has been reported in numerous systems1-3; however, whether and how such a response can be activated in the absence of protein feedback loops is unknown.  Here, we develop and analyze several models of transcriptional adaptation in zebrafish and mouse that we show are not caused by loss of protein function.  We find that the increase in transcript levels is due to enhanced transcription, and observe a correlation between the levels of mutant mRNA decay and transcriptional upregulation of related genes.  To assess the role of mutant mRNA degradation in triggering transcriptional adaptation, we use genetic and pharmacological approaches and find that mRNA degradation is indeed required for this process.  Notably, uncapped RNAs, themselves subjected to rapid degradation, can also induce transcriptional adaptation.  Next, we generate alleles that fail to transcribe the mutated gene and find that they do not show transcriptional adaptation, and exhibit more severe phenotypes than those observed in alleles displaying mutant mRNA decay.  Transcriptome analysis of these different alleles reveals the upregulation of hundreds of genes with enrichment for those showing sequence similarity with the mutated gene's mRNA, suggesting a model whereby mRNA degradation products induce the response via sequence similarity.  These results expand the role of the mRNA surveillance machinery in buffering against mutations by triggering the transcriptional upregulation of related genes.  Besides implications for our understanding of disease-causing mutations, our findings will help design mutant alleles with minimal transcriptional adaptation-derived compensation. Overall design: Examination of transcriptional adaptation based on 3 genes in 3 cell types. Actb was assessed in ESCs as a K.O. and full locus deletion and compared versus wild type (2 replicates each).  Actg1 was assessed in MEFs as a K.O. and full locus deletion and compared versus wild type (2 replicates each). Kindlin 2 was assessed in MKFs as a K.O. and and compared versus floxed (2 replicates each).